This report finds that use of mephedrone, a synthetic stimulant, has increased in recent years, particularly in the UK, Europe and Australia. The report also finds that: • One-fifth (21%) of the 2010 national regular ecstasy user sample reported lifetime use of mephedrone and 17% reported use of mephedrone in the six months preceding the interview. • Mephedrone was typically swallowed or snorted on a median frequency of 3 days or approximately once every two months. • Use of mephedrone was most common in particular jurisdictions such as Tasmania (47%) and Victoria (28%) followe
Objective: Recent reports in Europe suggest a decline in 3,4-methylenedioxymethamphetamine (MDMA; Ec...
Drug scenes within several countries have changed in recent years to incorporate a range of licit ps...
Aims: Use of the stimulant drug mephedrone increased dramatically in 2009, and it is still available...
Background: The past decade has seen the development of an array of emerging psychoactive substances...
New Psychoactive Substances are now a feature of Australia’s recreational drug market. Little is kno...
Introduction and Aims. Mephedrone (4-methylmethcathinone) is a synthetic stimulant that has recently...
Background: The aim of the study was to investigate the prevalence of injecting drug use and associa...
Background: In few last years we can see a rise of use of a new psychoactive substances, not only in...
This report presents findings of a community survey of 3,021 adolescents and young adults aged 14–24...
Aims:This paper examines the epidemiology of ecstasy use and harm in Australia using multiple data s...
Aims: This paper examines the epidemiology of ecstasy use and harm in Australia using multiple data ...
Purpose: In this fourth paper in a series on emergent drug trends in the UK (2006 ketamine, 2009 M...
Background/Aims: To assess whether novel psychoactive substances (NPS) displace established club dru...
Background/Aims: To assess whether novel psychoactive substances (NPS) displace established club dru...
Introduction. This study examined (a) changes in crystal methamphetamine use among regular ecstasy u...
Objective: Recent reports in Europe suggest a decline in 3,4-methylenedioxymethamphetamine (MDMA; Ec...
Drug scenes within several countries have changed in recent years to incorporate a range of licit ps...
Aims: Use of the stimulant drug mephedrone increased dramatically in 2009, and it is still available...
Background: The past decade has seen the development of an array of emerging psychoactive substances...
New Psychoactive Substances are now a feature of Australia’s recreational drug market. Little is kno...
Introduction and Aims. Mephedrone (4-methylmethcathinone) is a synthetic stimulant that has recently...
Background: The aim of the study was to investigate the prevalence of injecting drug use and associa...
Background: In few last years we can see a rise of use of a new psychoactive substances, not only in...
This report presents findings of a community survey of 3,021 adolescents and young adults aged 14–24...
Aims:This paper examines the epidemiology of ecstasy use and harm in Australia using multiple data s...
Aims: This paper examines the epidemiology of ecstasy use and harm in Australia using multiple data ...
Purpose: In this fourth paper in a series on emergent drug trends in the UK (2006 ketamine, 2009 M...
Background/Aims: To assess whether novel psychoactive substances (NPS) displace established club dru...
Background/Aims: To assess whether novel psychoactive substances (NPS) displace established club dru...
Introduction. This study examined (a) changes in crystal methamphetamine use among regular ecstasy u...
Objective: Recent reports in Europe suggest a decline in 3,4-methylenedioxymethamphetamine (MDMA; Ec...
Drug scenes within several countries have changed in recent years to incorporate a range of licit ps...
Aims: Use of the stimulant drug mephedrone increased dramatically in 2009, and it is still available...